Study of Alternate Formulation of Aripiprazole in Agitated Patients With Schizophrenic Disorders
Clinical trial NCT00036127 · COMPLETED
Trial details
- NCT number
- NCT00036127
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-04-01
- Primary completion
- 2003-01-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.